Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
Joint Authors
Grieco, Antonio
Gasbarrini, Antonio
Boccia, Stefania
Turati, Federica
Rapaccini, Gianlodovico
La Vecchia, Carlo
Bosetti, C.
Miele, Luca
Source
Gastroenterology Research and Practice
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-05-13
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Introduction.
Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk.
We have further analyzed the role of diabetes and antidiabetic treatments on HCC.
Methods.
Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC patients and 389 controls.
Odds ratios (ORs) were estimated using multiple logistic regression models.
Results.
Sixty-nine (30.9%) cases versus 52 (13.5%) controls reported a diabetes diagnosis, corresponding to a multivariate OR of 2.25 (95% confidence interval, CI = 1.42–3.56).
A stronger excess risk emerged for a longer time since diabetes diagnosis (OR = 2.96 for <10 years and 5.33 for ≥10 years).
Oral therapies were inversely, though not significantly, related to HCC risk, OR being 0.44 for metformin and 0.88 for sulfonylureas; conversely, insulin was nonsignificantly directly associated (OR = 1.90).
Compared to nondiabetic subjects who were never smokers, those who were diabetics and ever smokers had an OR of 6.61 (95% CI 3.31–13.25).
Conclusion.
Our study confirms an over 2-fold excess HCC risk in diabetics, with a stronger excess risk in diabetic subjects who are also tobacco smokers.
Metformin may decrease the risk of HCC, whereas insulin may increase the risk.
American Psychological Association (APA)
Miele, Luca& Bosetti, C.& Turati, Federica& Rapaccini, Gianlodovico& Gasbarrini, Antonio& La Vecchia, Carlo…[et al.]. 2015. Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterology Research and Practice،Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1064051
Modern Language Association (MLA)
Miele, Luca…[et al.]. Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterology Research and Practice No. 2015 (2015), pp.1-5.
https://search.emarefa.net/detail/BIM-1064051
American Medical Association (AMA)
Miele, Luca& Bosetti, C.& Turati, Federica& Rapaccini, Gianlodovico& Gasbarrini, Antonio& La Vecchia, Carlo…[et al.]. Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterology Research and Practice. 2015. Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1064051
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1064051